Metraipolis › archive › dc_05ab57bca9f6

Temporal optimization of CD25-biased IL-2 agonists and immune checkpoint blockade leads to synergistic anticancer activity despite robust regulatory T cell… — Europe PMC PMID:40789741

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40789741
DOI: 10.1136/jitc-2024-010465
License (as archived): solo-consultazione
Archived: 2026-11-10T18:21:48.812Z
SHA-256 of the archived text: e47b740e0a7677622e8b87b7f3bd5621b55e6ba96faacd21b538d9da7d01b3a3
Stable URL of this page: https://metraipolis.com/documento/dc_05ab57bca9f6

How to cite

Temporal optimization of CD25-biased IL-2 agonists and immune checkpoint blockade leads to synergistic anticancer activity despite robust regulatory T cell… — Europe PMC PMID:40789741 — Europe PMC (en), https://europepmc.org/article/MED/40789741 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_05ab57bca9f6 (Metraipolis archive dc_05ab57bca9f6, sha256 e47b740e0a7677622e8b87b7f3bd5621b55e6ba96faacd21b538d9da7d01b3a3)

BibTeX

@misc{dc05ab57bca9f6,
  title = {Temporal optimization of CD25-biased IL-2 agonists and immune checkpoint blockade leads to synergistic anticancer activity despite robust regulatory T cell… — Europe PMC PMID:40789741},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40789741},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_05ab57bca9f6; sha256 e47b740e0a7677622e8b87b7f3bd5621b55e6ba96faacd21b538d9da7d01b3a3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40789741. Agents can read the archived copy with the MCP tool read_document.